Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 19/10/2018
SIETES contiene 92571 citas

 
 
 1 a 20 de 32 siguiente >>
Presentar resultados
Seleccionar todas
2. Cita con resumen
Hakkarainen KM, Alström D, Hägg S, Carlsten A, Gyllensten H. Modelling drug-related morbidity in Sweden using an expert panel pf physicians. Eur J Clin Pharmacol 2012;68:1309-19. [Ref.ID 93648]
3. Cita con resumen
Hakkarainen KM, Hedna K, Petzold M, Hägg S. Percentage of patients with preventable adverse drug reactions and preventability of adverse drug reactions - A meta-analysis. PLOS ONE 2012;7:e33236. [Ref.ID 92107]
4. Cita con resumen
Olivier P, Montastruc J-L. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France. Pharmacoepidemiol Drug Saf 2006;15:808-12. [Ref.ID 88737]
5. Cita con resumen
Jönsson AK, Hakkarainen KM, Spigset O, Druid H, Hiselius A, Hägg S. Preventable drug related mortality in a Swedish population. Pharmacoepidemiol Drug Saf 2010;19:211-5. [Ref.ID 87697]
6. Cita con resumen
Trinh-Duc A, Doucet J, Bannwarth B, Trombert-Paviot B, Carpentier F, Bouget J, Queneau P, et au nom de l'Association Pédagogique Nationale pour l'Enseignement de la Thérapeutique (APNET). Admissions des sujets âgés aux Services d'Accueil des Urgences pour effets indésirables médicamenteux. Therapie 2007;62:437-41. [Ref.ID 81068]
7. Cita con resumen
Day RO, Williams KM. Open-label extension studies: do they provide meaningful information on the safety of new drugs?. Drug Saf 2007;30:93-105. [Ref.ID 79290]
8.Tiene citas relacionadas Cita con resumen
Trotter CL, McVernon J, Andrews NJ, Burrage M, Ramsay M E. Antibody to Haemophilus influenzae type b afte routine and catch-up vaccination. Lancet 2003;361:1523-4. [Ref.ID 65987]
9.Tiene citas relacionadas Cita con resumen
McVernon J, Andrews N, Slack MPE, Ramsay M E. Risk of vaccine failure after Haemophilus influenzae type b (Hib) combination vaccines with acellular pertussis. Lancet 2003;361:1521-3. [Ref.ID 65986]
10.Tiene citas relacionadas Cita con resumen
Molyneux EM, Walsh AL, Forsyth H, Tembo M, Mwenechanya J, Kayira K, Bwanaisa L, Njobvu A, Rogerson S, Malenga G. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 2002;360:211-8. [Ref.ID 63145]
11. Cita con resumen
Stark K, Günther M, Schönfeld C, Tullius SG, Bienzle U. Immunisations in solid-organ transplant recipients. Lancet 2002;359:957-65. [Ref.ID 61194]
12. Cita con resumen
Gruchalla RS. Clinical assessment of drug-induced disease. Lancet 2000;356:1505-11. [Ref.ID 53693]
13. Cita con resumen
Knowles SR, Uetrecht J, Shear NH. Idiosyncratic drug reactions: the reactive metabolite syndromes. Lancet 2000;356:1587-91. [Ref.ID 53552]
14.
15. Cita con resumen
Ward BJ. Vaccine adverse events in the new millennium: is there reason for concern?. Bulletin of the World Health Organization 2000;78:205-15. [Ref.ID 49496]
16.
Dellepiane N, Griffiths E, Milstien J B. New challenges in assuring vaccine quality. Bulletin of the World Health Organization 2000;78:155-62. [Ref.ID 49489]
17. Cita con resumen
Bedford H, Elliman D. Concerns about immunisation. BMJ 2000;320:240-3. [Ref.ID 48981]
18. Cita con resumen
Otero López MJ, Bajo Bajo A, Maderuelo JA, Domínguez-Gil Hurlé A. Evitabilidad de los acontecimientos adversos inducidos por medicamentos detectados en un servicio de Urgencias. Rev Clin Esp 1999;199:796-805. [Ref.ID 48524]
19. Cita con resumen
Seleccionar todas
 
 1 a 20 de 32 siguiente >>